Other acanthamebic disease
ICD-10 B60.19 is a billable code used to indicate a diagnosis of other acanthamebic disease.
Acanthamoeba is a genus of free-living amoebae that can cause a range of diseases in humans, primarily affecting the eyes, skin, and central nervous system. Acanthamoebic disease is most commonly associated with keratitis, particularly in contact lens wearers, but can also manifest as granulomatous amebic encephalitis (GAE) and disseminated infections in immunocompromised individuals. The organism is ubiquitous in the environment, found in soil, water, and air, and can enter the body through broken skin, inhalation, or the eyes. Symptoms vary depending on the site of infection; for instance, keratitis may present with eye pain, redness, and blurred vision, while GAE may present with neurological symptoms such as headache, fever, and altered mental status. Diagnosis typically involves clinical evaluation, imaging studies, and laboratory tests, including culture and PCR. Treatment often includes a combination of antifungal and antiparasitic medications, such as propamidine isethionate and chlorhexidine, although the prognosis can be poor, especially in cases of GAE.
Detailed eye examination findings, including visual acuity and corneal assessment.
Patients presenting with eye pain, redness, and contact lens use history.
Ensure documentation includes all relevant symptoms and treatment responses.
Comprehensive patient history, including immunocompromised status and exposure history.
Patients with neurological symptoms and a history of environmental exposure.
Document all diagnostic tests and treatment regimens thoroughly.
Used when a biopsy is performed to confirm acanthamoebic infection.
Pathology report must indicate the presence of Acanthamoeba.
Ophthalmology and Infectious Disease specialists should ensure thorough documentation.
Common symptoms include eye pain, redness, blurred vision for keratitis, and headache, fever, and neurological symptoms for GAE.
